DAVITA INC.
DaVita Inc. is a leading healthcare provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S., with over 2,675 outpatient dialysis centers in 46 states and the District of Columbia, serving approximately 200,800 patients. DaVita also provides hospital inpatient dialysis services in approximately 790 hospitals throughout the U.S. and operates a separately licensed clinical laboratory which specializes in ESKD patient testing. The company's business strategy is to provide comprehensive kidney care services, including dialysis, laboratory services, and management services to patients with chronic kidney disease (CKD) and end stage renal disease (ESRD). DaVita's care model leverages its platform of kidney care services to maximize patient choice in both models and modalities of care, with a focus on comprehensive kidney care and value-based care arrangements. DaVita's U.S. dialysis revenues represent approximately 89% of its consolidated revenues and are derived primarily from government-based programs, including Medicare and Medicaid, and commercial insurance plans. The company's website is located at http://www.davita.com and its ticker symbol is DVA.